Lavonne Patton

Single-Blind Study of the Effects of Intravenous Dolasetron Mesylate Versus Ondansetron on Electrocardiographic Parameters in Normal Volunteers

Claude R. Benedict, Robert Arbogast, Lorene A. Martin et al. · Journal of Cardiovascular Pharmacology · 1996 · 104 citations

Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies

Mark D. Minden, Donna E. Hogge, Scott J. Weir et al. · American Journal of Hematology · 2013 · 95 citations · Full text

Advanced Hematologic Malignancies, Pharmacotherapy, Pharmacodynamic Modeling +16

Early Drug Discovery and Development Guidelines: For Academic Researchers, Collaborators, and Start-up Companies

Jeffrey Strovel, Sitta Sittampalam, Nathan P. Coussens et al. · 2016 · 57 citations

Drug Repositioning, Oncology, Drug Target +15

The repositioning of the anti-fungal agent ciclopirox olamine as a novel therapeutic agent for the treatment of haematologic malignancy

Scott J. Weir, Lavonne Patton, Katherine D. Castle et al. · Journal of Clinical Pharmacy and Therapeutics · 2010 · 39 citations